RECURSION PHARMACEUTICALS INC. - CLASS A COMMON S

Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer

16 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conference

02 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire

Recursion Publishes Annual Environmental, Social and Governance Report

26 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire

Recursion Announces Plans to Open New Office in London

11 мар 2024 03:00:00 Источник Nasdaq GlobeNewswire

Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community

01 мар 2024 13:58:00 Источник Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

01 мар 2024 06:59:00 Источник Nasdaq GlobeNewswire

Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results

27 фев 2024 15:05:11 Источник Nasdaq GlobeNewswire

Recursion to Host Public L(earnings) Call on February 27

20 фев 2024 06:59:00 Источник Nasdaq GlobeNewswire

Altitude Lab Startups Raise Over $120M in Capital

24 янв 2024 08:00:00 Источник Nasdaq GlobeNewswire

Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference

08 янв 2024 09:59:00 Источник Nasdaq GlobeNewswire

Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline

04 янв 2024 06:59:00 Источник Nasdaq GlobeNewswire

Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8

03 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire

Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry

20 дек 2023 06:59:00 Источник Nasdaq GlobeNewswire

Bayer and Recursion Focus Research Collaboration on Oncology

09 ноя 2023 08:41:30 Источник Nasdaq GlobeNewswire

Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology

09 ноя 2023 07:01:00 Источник Nasdaq GlobeNewswire

Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results

09 ноя 2023 06:58:00 Источник Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conference

02 ноя 2023 07:05:00 Источник Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

05 сен 2023 15:30:00 Источник Nasdaq GlobeNewswire

Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection

05 сен 2023 06:59:00 Источник Nasdaq GlobeNewswire

Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds

08 авг 2023 07:00:01 Источник Nasdaq GlobeNewswire